Efficient derivation of microglia-like cells from human pluripotent stem cells
Open accessAbstract
Microglia, the only lifelong resident immune cells of the central nervous system (CNS), are highly specialized macrophages that have been recognized to have a crucial role in neurodegenerative diseases such as Alzheimer's, Parkinson's and adrenoleukodystrophy (ALD). However, in contrast to other cell types of the human CNS, bona fide microglia have not yet been derived from cultured human pluripotent stem cells. Here we establish a robust and efficient protocol for the rapid production of microglia-like cells from human (h) embryonic stem (ES) and induced pluripotent stem (iPS) cells that uses defined serum-free culture conditions. These in vitro pluripotent stem cell–derived microglia-like cells (termed pMGLs) faithfully recapitulate the expected ontogeny and characteristics of their in vivo counterparts, and they resemble primary fetal human and mouse microglia. We generated these cells from multiple disease-specific cell lines and find that pMGLs derived from an hES model of Rett syndrome are smaller than their isogenic controls. We further describe a platform to study the integration and live behavior of pMGLs in organotypic 3D cultures. This modular differentiation system allows for the study of microglia in highly defined conditions as they mature in response to developmentally relevant cues, and it provides a framework in which to study the long-term interactions of microglia residing in a tissue-like environment.
AI snapshot
Written from the paper’s full text.
TL;DR
The paper establishes a defined, serum-free protocol to derive microglia-like cells (pMGLs) from human ES and iPS cells, including disease-specific lines, and shows they resemble primary human fetal microglia phenotypically and transcriptionally. pMGLs are phagocytic, respond to inflammatory stimuli, integrate into 3D neuroglial cultures, and can model injury responses and isogenic disease phenotypes such as MECP2 mutant size differences.
Key findings
- pMGLs were generated from 20 different human ES and iPS cell lines representing healthy and disease genotypes, with successful derivation from all lines; after 8 weeks, example yields from 2×10^6 pluripotent stem cells included 1×10^6 (hES-wibr1), 1×10^6 (iPS-wt1), 3×10^6 (iPS-wt4), 2×10^6 (iPS-ALD4), and 8×10^6 (iPS-ALD1) microglia-like cells.
- pMGLs expressed microglial markers including TMEM119, P2RY12, IBA1, CD11b, CD45, and PU.1; transcriptomic clustering placed pMGLs with primary fetal and adult human microglia, separate from other macrophages, and they expressed high levels of microglial genes such as APOE, CD33, TREM2, HEXB, GPR34, and P2RY12/13.
- Functionally, pMGLs were highly phagocytic and motile; early pMGLs showed EdU incorporation in 60% of nuclei, falling to less than 5% after 2 months in culture. IFN-γ/LPS stimulation increased release of CXCL10, MIP1a, IL-6, and TNFα more than 2-fold, with corresponding increases in IL-6 and TNFα mRNA.
- pMGLs derived from isogenic MECP2 mutant hES cells were significantly smaller than wild-type controls; in 3D organotypic cultures, GFP-labeled pMGLs integrated, tiled the volume, extended highly branched ramifications, and responded to focal laser injury by extending processes and migrating toward damage within minutes.
Methods
- Differentiation used human ES/iPS cells grown on murine embryonic fibroblasts, collagenase-passaged into uniform clusters, and seeded in ultra-low-adherence plates in NGD serum-free medium containing 10 ng/mL CSF1 and 10 ng/mL IL-34 (MGdM). After one week, yolk sac-like embryoid bodies (YS-EBs) formed; semi-adherent cells were harvested onto Primaria plates and maintained in MGM (NGD + 100 ng/mL IL-34 + 5 ng/mL CSF1).
- Characterization included immunofluorescence, flow cytometry, phagocytosis assays, EdU click-it proliferation assays, cytokine antibody arrays, qPCR, and RNA-seq (SMART-Seq v4, hg19 mapping, TopHat, FeatureCounts, DESeq, PCA, hierarchical clustering). 3D organotypic cultures were made by transducing pMGLs with GFP lentivirus and re-aggregating them with pre-differentiated neural cultures, followed by live imaging and two-photon laser injury.
- The study states no statistical tests were used to pre-determine sample size; experimenters were not blinded to genotypes or culture conditions except for transcriptomic analysis where line genotype was not explicit. Two-tailed Student’s t-tests were used where appropriate, with p<0.05 considered significant.
Limitations
- Stated: primary human microglia are poorly characterized, not easily accessible, and current isolation methods likely alter their defining characteristics; the protocol yields “microglia-like” cells (pMGLs) rather than bona fide primary microglia, and the genetic background of the pluripotent donor affects kinetics and yield.
- Stated: no statistical tests were used to pre-determine sample size, and experimenters were not blinded to genotypes or culture conditions except for transcriptomic analysis.
- Evident: the transcriptomic comparison relies on primary fetal human microglia maintained in the same culture conditions, and the MECP2 mutant size difference is reported as a finding worthy of further investigation rather than a functional mechanism; long-term in vivo behavior and disease relevance remain to be established.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 45 cited sources checked · 0 supported · 0 flagged
- Findingown data
pMGLs were generated from multiple disease-specific cell lines.
“We generated these cells from multiple disease-specific cell lines”
Quote in the paperNot a substantial claim - Findingown data
pMGLs derived from MeCP2 mutant hES cells are smaller than their isogenic controls.
“find that pMGLs derived from MeCP2 mutant hES cells are smaller than their isogenic controls.”
- Also stated in: § Phenotypic and functional characterization of pMGLs · plain
“We derived pMGLs from isogenic male wild-type and MECP2 mutant cells, and observed that mutant cells were significantly smaller than the wild-type cells (Fig. 3c).”
Quote in the paperNot a substantial claim - Also stated in: § Phenotypic and functional characterization of pMGLs · plain
- Findingown data
Human fetal microglia adopted a more ramified morphology in the presence of high concentrations of IL-34.
“with hFMGs adopting a more ramified morphology in the presence of high concentrations of IL-34 (Supplementary Fig 1a, b).”
Quote in the paperNot a substantial claim - Findingown data
The majority of cells physically selected by the growth conditions were positive for all markers.
“with the majority of cells physically selected by the growth conditions positive for all markers.”
Quote in the paperSubstantial claim - Findingcitation
Neural differentiation can be initiated in NGD by adding dorsomorphin.
“Neural differentiation can be initiated in NGD by addition of a small molecule inhibitor of TGFβ signaling (dorsomorphin) 15.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [15] Zhou, J. et al. High-efficiency induction of neural conversion in human ESCs and human induced pluripotent stem cells with a single chemical inhibitor of transforming growth factor beta superfamily receptors. Stem Cells 28, 1741–1750 (2010). source
Not checked in the free run.
- Findingown data
Large domains of YS-EBs were positive for the master myeloid transcription factor PU.1.
“Large domains of the YS-EBs were positive for the master myeloid transcription factor PU.1 (Fig. 1d)”
Quote in the paperSubstantial claim - Findingreasoning
Differentiation into neurons and glia can be triggered by removing FGF2.
“differentiation into neurons and glia can be subsequently triggered by FGF2 removal.”
Quote in the paperNot a substantial claim - Findingown data
Primaria plates allow adherent maintenance of mouse neonatal microglia and human fetal microglia while permitting enzymatic passaging.
“we used commercially available modified polystyrene (Primaria) plates that allow adherent maintenance of mouse neonatal microglia and human fetal microglia (mNMG and hFMG, respectively) while maintaining the possibility of enzymatic passaging (Supplementary Fig. 1a).”
Quote in the paperSubstantial claim- Rests on an assumption: Neuroglial derivatives from neural progenitors are poorly adherent on Primaria and are therefore selected against by this substrate.
- Findingown data
Proliferation and growth of attached structures depended on CSF1R ligand, as they arrested and devolved without CSF1 and IL-34.
“Proliferation and growth of these structures after attachment is CSF1R-ligand dependent, as they arrested and devolved in absence of CSF1 and IL-34 (not shown).”
Quote in the paperSubstantial claim - Findingown data
After one week, dense neuralized spheroids and cystic embryoid bodies bound by a single cell layer formed.
“After one week, we observed the formation of two types of structures: dense neuralized spheroids appearing alongside embryoid bodies forming cystic structures, bound by a single cell layer (Fig. 1a).”
Quote in the paperNot a substantial claim - Findingown data
The effect was detectable at the transcriptional level, with an increase in mRNA of IL-6 and TNFα.
“We verified that this effect was detectable at the transcriptional level, with an increase in mRNA of IL-6 and TNFα (Fig. 4c, d).”
Quote in the paperSubstantial claim - Findingown data
pMGLs differ in enrichment of gene categories related to establishment and modulation of the extracellular matrix.
“pMGLs differ in the enrichment of gene categories related to the establishment and modulation of the extracellular matrix (ECM, Suppl. Tables 4 and 5).”
Quote in the paperNot a substantial claim - Findingown data
The authors established a robust and efficient protocol for rapid production of microglia-like cells from human ES and iPS cells using defined serum-free culture conditions.
“Here we establish a robust and efficient protocol for the rapid production of microglia-like cells from human embryonic stem (ES) and induced pluripotent stem (iPS) cells that uses defined serum-free culture conditions.”
Quote in the paperSubstantial claim - Findingreasoning
NGD is a single defined serum-free medium that supports culture of multiple neural and glial cell types and other cells of interest.
“NGD constitutes a single defined serum-free medium allowing culture of multiple neural and glial cell types, as well as other cells of interest.”
Quote in the paperSubstantial claim - Findingown data
Addition of IFN-γ and LPS triggered release of chemokines and cytokines above baseline.
“Furthermore, the addition of IFN-γ and endotoxin (LPS) triggered the release of chemokine and cytokines above baseline (Fig. 4a–d).”
Quote in the paperSubstantial claim - Findingown data
Unstimulated pMGLs secreted detectable levels of various cytokines and chemokines, including IL-8, CXCL1 or CCL2.
“Unstimulated pMGLs secreted detectable levels of various cytokines and chemokines, including IL-8, CXCL1 or CCL2 (Fig. 4a, b).”
Quote in the paperNot a substantial claim - Findingown data
After 8 weeks of differentiation, five specific cell lines generated between 1 million and 8 million microglia-like cells from 2 million pluripotent stem cells at onset.
“after 8 weeks of differentiation, hES-wibr1, iPS-wt1, iPS-wt4, iPS-ALD4 and iPS-ALD1 respectively generated 1×106, 1×106, 3×106, 2×106, and 8×106 microglia-like cells, from 2×106 pluripotent stem cells at the onset.”
Quote in the paperSubstantial claim - Findingown data
Top GO categories coincide between pMGLs and fetal human microglia.
“Supplementary Table 3 shows that the top GO categories coincide between both cell types.”
Quote in the paperSubstantial claim - Findingown data
The majority of pMGLs at this stage were positive for TMEM119, IBA1 and CD45.
“The majority of pMGLs at this stage were positive for TMEM119, IBA1 and CD45 (Fig. 3g).”
Quote in the paperSubstantial claim - Findingown data
Primary human fetal microglia and pMGLs derived from hES or hiPS cells adopted an identical morphology characterized by multiple thin first-order branching terminated by actively motile membrane ruffles around an immobile soma.
“primary human FMGs and pMGLs derived from hES or hiPS cells adopted an identical morphology, characterized by multiple thin first-order branching terminated by actively motile membrane ruffles, around an immobile soma.”
Quote in the paperSubstantial claim - Findingown data
pMGLs were successfully generated from all 20 different ES and iPS cell lines representing healthy and disease genotypes.
“we induced microglia from 20 different ES and iPS cell lines representing a panel of healthy and disease genotypes (Supplementary Table 2), and successfully generated pMGLs from all lines.”
Quote in the paperSubstantial claim - Findingnone given
A culture platform was developed to study integration and live behavior of pMGLs in organotypic 3D cultures.
“We further describe a culture platform to study integration and live behavior of pMGLs in organotypic 3D-cultures.”
Quote in the paperSubstantial claim - Findingown data
Initially, EdU incorporation was seen in 60% of nuclei from early pMGLs at 2 weeks from onset of production.
“Initially, EdU incorporation was seen in 60% of nuclei from early pMGLs (2 weeks from onset of production).”
Quote in the paperNot a substantial claim - Findingown data
A fully defined serum-free Neuro-Glial Differentiation medium was developed with component concentrations adjusted to match human cerebrospinal fluid.
“we have developed a fully-defined, serum-free Neuro-Glial Differentiation media (referred to as NGD), the component concentrations of which were adjusted to match those of human cerebrospinal fluid (Supplementary Table 1).”
Quote in the paperSubstantial claim - Findingown data
Both primary fetal microglia and pMGLs could be maintained for several months in culture despite ultimately limited renewal potential.
“Importantly, both primary fetal microglia and pMGLs could be maintained for several months in culture despite ultimately limited renewal potential, demonstrating their longevity.”
Quote in the paperNot a substantial claim - Findingown data
pMGLs display a signature strikingly resembling that of fetal human microglia kept in the same conditions.
“We found that pMGLs display a signature strikingly resembling that of fetal human microglia kept in the same conditions.”
Quote in the paperSubstantial claim- Rests on an assumption: Human fetal microglia maintained in the same culture conditions retain characteristics of bona fide primary microglia and are a valid reference for comparison.
- Findingown data
CXCL10, MIP1a, IL-6 and TNFα were increased more than 2-fold within the dynamic range of the assay.
“In particular, CXCL10, MIP1a, IL-6 and TNFα were increased more than 2-fold within the dynamic range of this assay.”
Quote in the paperSubstantial claim - Findingown data
After 2 months in culture, less than 5% of pMGLs kept in MGdM were mitotic within a 24-hour period.
“After 2 months in culture, EdU incorporation showed that less than 5% of pMGLs kept in MGdM were mitotic within a 24-hour period (Fig. 2h).”
Quote in the paperNot a substantial claim - Findingown data
Primary cells could be maintained in this medium for more than a month without passaging.
“Primary cells could be maintained in this medium for more than a month without passaging”
Quote in the paperNot a substantial claim - Findingown data
Cells at island borders and in three-dimensional ropes were positive for VE-Cadherin, c-kit CD41 and CD235a.
“The cells at the island borders and in the three-dimensional ropes were positive for VE-Cadherin, c-kit CD41 and CD235a (Fig. 1b,c)”
Quote in the paperSubstantial claim - Findingown data
Genes expected to be highly expressed in peripheral macrophages and low in microglia, such as SLPI, SAA1/2, PRG4, CFP, CD5l and CRIP1, are in the lower expression quartile of the dataset.
“genes such SLPI, SAA1/2, PRG4, CFP, CD5l, CRIP1 are expected to be highly expressed in peripheral macrophages, and low in microglia 11: these genes are in the lower expression quartile of our dataset.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [11] Hickman, S.E. et al. The microglial sensome revealed by direct RNA sequencing. Nat. Neurosci. 16, 1896–1905 (2013). source
Not checked in the free run.
- Findingown data
Live imaging showed rapid extension and retraction of filopodial arbor termini of GFP-positive pMGL branches in situ.
“Live Imaging of the GFP positive pMGL branches in situ showed rapid extension and retraction of filopodial arbor termini (Fig. 6f, g and Supplementary Movies 6, 7).”
Quote in the paperSubstantial claim - Findingown data
Transcriptome sequence analysis shows that pMGLs resemble human primary fetal and adult microglia, unlike other macrophages.
“Transcriptome sequence analysis shows that they resemble human primary fetal and adult microglia, unlike other macrophages.”
Quote in the paperSubstantial claim - Findingown data
The 3D culture matrix is a cortex-like mesh of MAP2 positive neurites and GFAP positive astrocytic branches.
“The 3D culture matrix is a cortex-like mesh of MAP2 positive neurites and GFAP positive astrocytic branches (Fig. 6e).”
Quote in the paperNot a substantial claim - Findingown data
Embedded GFP-positive microglia reacted within minutes to focal laser injury by extending a single long process towards the injury center, making contact at t=20 minutes.
“Microglia reacted within minutes by extending a single long process towards the injury center, making contact with the damaged zone (t =20′).”
Quote in the paperSubstantial claim - Findingnone given
Addition of IL-34 to the base medium improved the morphological phenotype of microglia-like cells.
“Addition of the recently identified alternative ligand for CSF1R, Interleukin-34 (IL-34) to the base medium improved the morphological phenotype of microglia-like cells.”
Quote in the paperSubstantial claim - Findingown data
After 2 weeks in conditioned medium from differentiating neural cultures, pMGLs partially shifted their signature towards primary microglia along the PC2 axis.
“Fig. 6b shows that, after 2 weeks, the pMGLs partially shifted their signature towards that of primary microglia along the PC2 axis.”
Quote in the paperSubstantial claim - Findingown data
Most consensus microglial genes are expressed at higher levels in pMGLs than in primary human fetal microglia.
“Most of these genes are in fact expressed at higher levels in pMGLs than in primary human fetal microglia (Fig. 5A, supplementary Fig. 2), supporting their identity as in vitro generated microglia.”
Quote in the paperSubstantial claim - Findingown data
When placed in a differentiated neuro-glial environment, pMGLs develop canonical high-order branching patterns.
“pMGLs further adopt canonical high-order branching patterns once embedded in a differentiated neuro-glial environment.”
Quote in the paperSubstantial claim - Findingnone given
Immature pMGLs delaminate and adopt directly a macrophage identity, with no colony-forming intermediate.
“Immature pMGLs delaminate and adopt directly a macrophage identity, with no colony-forming intermediate.”
Quote in the paperSubstantial claim - Findingown data
MECP2 mutant microglia are smaller than their isogenic control microglia.
“We showed that MECP2 mutant microglia are smaller than their isogenic counterpart: this may contribute to functional differences in Rett microglia worthy of further investigation.”
Quote in the paperSubstantial claim - Findingown data
All myeloid cells cluster away from parental iPS cells and neural progenitor cells.
“As expected, all myeloid cells cluster away from parental iPS cells and NPCs.”
Quote in the paperNot a substantial claim - Findingnone given
pMGLs eventually settle into a highly ramified morphology, enhanced by co-culture with differentiated neurons and glia.
“They eventually settle into a highly ramified morphology, enhanced by co-culture with differentiated neurons and glia.”
Quote in the paperNot a substantial claim - Findingown data
pMGLs highly expressed genes relevant to nervous system disorders such as APOE, CD33 and TREM2.
“In addition, pMGLs highly expressed genes relevant to nervous system disorders such as APOE, CD33 and TREM2 (Supplementary Fig. 2b).”
Quote in the paperSubstantial claim - Findingown data
pMGLs and primary fetal microglia cluster together, separately from other macrophages.
“Strikingly, we find that pMGLs and primary fetal microglia cluster together, separately from other macrophages (Suppl. Figure 3b).”
Quote in the paperSubstantial claim - Findingown data
Neural progenitors derived from the same pluripotent stem cells and differentiated into neurons and glia express these genes at much lower levels.
“Neural progenitors derived from the same pluripotent stem cells and further differentiated into complex cultures of neurons and glia (Diff. NPCs, see Fig. 6), express these genes to much lower levels (Fig. 5 and Supplementary Fig. 2)”
Quote in the paperSubstantial claim - Findingown data
They then rapidly migrated their cell body to surround the damaged area.
“They then rapidly migrated their cell body to surround the damaged area.”
Quote in the paperSubstantial claim - Findingnone given
When cultured in isolation, pMGLs lose their ability to proliferate.
“Likewise, pMGLs progressively adopt a ramified morphology when cultured in isolation, as they lose their proliferation potential.”
Quote in the paperNot a substantial claim - Findingown data
Microglia away from the injury site stayed in place.
“In contrast, microglia away from the injury site stayed in place.”
Quote in the paperSubstantial claim - Findingnone given
pMGLs secrete highly bioactive cytokines and chemokines.
“pMGLs are capable of major and rapid morphological changes, as well as secretion of highly bioactive cytokines and chemokines.”
Quote in the paperNot a substantial claim - Findingown data
pMGLs express many markers expected to be characteristic of microglial expression phenotypes, such as P2RY12/13, HEXB, GPR34 and TMEM119.
“These cells express many of the markers expected to be characteristic of microglial expression phenotypes, such as P2RY12/13, HEXB, GPR34 and TMEM119.”
Quote in the paperSubstantial claim - Findingown data
Several individual genes were highly expressed in primary human fetal microglia and pMGLs, consistent with their identity.
“Several individual genes were highly expressed in primary human fetal microglia and pMGLs, consistent with their identity (Suppl. Fig. 2a).”
Quote in the paperSubstantial claim - Findingown data
The magnitude of extension and retraction observed in 3D is not observed in 2D cultures on Primaria or glass coverslips, where non-amoeboid pMGLs only display terminal ruffle movement on a much smaller scale.
“We note that this magnitude of extension and retraction is not observed in 2D cultures on Primaria or glass coverslips, where non-amoeboid pMGLs only display terminal ruffle movement, on a much smaller scale.”
Quote in the paperSubstantial claim - Findingown data
Among the highly expressed genes were CD11b (ITGAM), ITGB2, CSF1R, CD45, IBA1, ADORA3 and LGMN.
“Among those genes were CD11b (ITGAM), ITGB2, CSF1R, CD45, IBA1, ADORA3 or LGMN.”
Quote in the paperSubstantial claim - Findingnone given
pMGLs can undergo major and rapid morphological changes.
“pMGLs are capable of major and rapid morphological changes, as well as secretion of highly bioactive cytokines and chemokines.”
Quote in the paperNot a substantial claim - Findingown data
Principal component analysis revealed that primary fetal microglia and pMGLs cluster tightly together along PC1 and segregate away from differentiated neural progenitors cultured in the same conditions.
“Principal component analysis of the transcriptome revealed that primary fetal microglia and pMGLs cluster tightly together along PC1, and segregate away from differentiated neural progenitors cultured in the same conditions (Fig. 6b).”
Quote in the paperSubstantial claim - Findingown data
HEXB was highly expressed in pMGLs.
“Likewise, HEXB, a causal gene for the lysosomal storage Sandhoff disease, was highly expressed in pMGLs”
Quote in the paperNot a substantial claim - Findingown data
Differentially expressed genes between primary cells and pMGLs did not include canonical myeloid ontology terms.
“The differentially expressed genes between primary cells and in vitro derived pMGLs did not include any of the canonical myeloid ontology terms”
Quote in the paperSubstantial claim - Findingreasoning
When cultured in isolation, pMGLs gradually develop a ramified morphology.
“Likewise, pMGLs progressively adopt a ramified morphology when cultured in isolation, as they lose their proliferation potential.”
Quote in the paperNot a substantial claim - Findingown data
In 3D re-aggregates, an entire spheroid or cellular stack self-assembles and lays down its own extracellular matrix without additional scaffold.
“In this context, an entire spheroid or cellular stack is self-assembling, laying down its own extracellular matrix without need for additional scaffold (Fig. 6a, lower panel).”
Quote in the paperNot a substantial claim - Premisecitation
Microglia-like cells matching acutely isolated microglial signatures and following non-monocytic yolk sac ontogeny had not been reported from human pluripotent cells.
“However, generation of microglia-like cells matching the recently identified signatures of acutely isolated microglia 10,11, and following their non-monocytic yolk sac ontogeny 4, has not been reported from pluripotent human cells.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [10] Bennett, M.L. et al. New tools for studying microglia in the mouse and human CNS. Proc. Natl. Acad. Sci. USA 113, E1738–E1746 (2016). source
Not checked in the free run.
- cites [11] Hickman, S.E. et al. The microglial sensome revealed by direct RNA sequencing. Nat. Neurosci. 16, 1896–1905 (2013). source
Not checked in the free run.
- cites [4] Ginhoux, F. et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330, 841–845 (2010). source
Not checked in the free run.
- Interpretationcitation
The marker expression pattern is consistent with these cells representing in vitro counterparts of early haemogenic endothelia.
“This immuno-histochemical panel is consistent with these cells representing the in vitro counterparts of early haemogenic endothelia 20.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [20] Sturgeon, C.M., Ditadi, A., Awong, G., Kennedy, M. & Keller, G. Wnt signaling controls the specification of definitive and primitive hematopoiesis from human pluripotent stem cells. Nat. Biotechnol. 32, 554–561 (2014). source
Not checked in the free run.
- Premisereasoning
In vitro models of CNS disorders using human iPS and ES derived cultures lack microglia.
“In vitro approaches to model and study CNS disorders using human iPS and ES derived cultures are currently lacking this important component.”
Quote in the paperSubstantial claim - Premisecitation
These markers have been identified in mouse as markers of early yolk sac myelogenesis before definitive hematopoiesis or embryonic circulation.
“which have been identified in mouse as markers of early yolk sac myelogenesis before definitive hematopoiesis or the establishment of embryonic circulation (<E8.5) 19.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [19] Hoeffel, G. & Ginhoux, F. Ontogeny of tissue-resident macrophages. Front. Immunol. 6, 486 (2015). source
Not checked in the free run.
- Premisecitation
IL-34 and CSF1 are important for microglial differentiation and maintenance in vivo.
“IL-34 and CSF1g, important for microglia differentiation and maintenance in vivo 16,17, were added to the medium.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [16] Wei, S. et al. Functional overlap but differential expression of CSF-1 and IL-34 in their CSF-1 receptor-mediated regulation of myeloid cells. J. Leukoc. Biol. 88, 495–505 (2010). source
Not checked in the free run.
- cites [17] Wang, Y. et al. IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia. Nat. Immunol. 13, 753–760 (2012). source
Not checked in the free run.
- Interpretationown data
Variation along PC2, about 12% of sample variance, may be refined by tissue residency, extracellular matrix and cell-cell interactions.
“while the variation along PC2 (~12% of sample variance) may be refined by tissue residency, ECM and cell/cell interactions.”
Quote in the paperNot a substantial claim - Interpretationown data
The PU.1-high, IRF8-high, MYB-low expression pattern in pMGLs is consistent with microglia emerging from PU.1- and IRF8-dependent but MYB-independent cells.
“consistent with microglia emerging from PU.1 and IRF8-dependent, but MYB-independent cells 34–37.”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [34] Kierdorf, K. et al. Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways. Nat. Neurosci. 16, 273–280 (2013). source
Not checked in the free run.
- cites [35] Schulz, C. et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 336, 86–90 (2012). source
Not checked in the free run.
- cites [36] Hoeffel, G. et al. C-Myb+ erythro-myeloid progenitor-derived fetal monocytes give rise to adult tissue-resident macrophages. Immunity 42, 665–678 (2015). source
Not checked in the free run.
- cites [37] Ginhoux, F. & Guilliams, M. Tissue-resident macrophage ontogeny and homeostasis. Immunity 44, 439–449 (2016). source
Not checked in the free run.
- Interpretationown data
Expression of the same markers in pMGLs supports this ontogeny.
“Expression of the same markers in pMGLs supports this ontogeny.”
Quote in the paperSubstantial claim - Premisecitation
Unlike other tissue-resident macrophages, microglia derive from PU.1-positive, IRF8-positive, MYB-negative precursors.
“Unlike other tissue-resident macrophages, microglia derive from PU.1+/IRF8+/MYB− precursors 34,35.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [34] Kierdorf, K. et al. Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways. Nat. Neurosci. 16, 273–280 (2013). source
Not checked in the free run.
- cites [35] Schulz, C. et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 336, 86–90 (2012). source
Not checked in the free run.
- Interpretationreasoning
A robust protocol for generating and maintaining microglia from patients enables study of neuron-microglia interactions.
“The availability of a robust protocol to generate and maintain microglia from patients suffering from these conditions allows studying the interaction of neurons and microglia and will facilitate the investigation of these diseases in defined culture conditions.”
Quote in the paperSubstantial claim - Interpretationreasoning
The morphology and function of pMGLs in isolation can be examined for cell-autonomous phenotypes.
“In isolation, their morphology and function can be analyzed for cell-autonomous phenotypes.”
Quote in the paperSubstantial claim - Interpretationreasoning
The protocol will aid investigation of these diseases under defined culture conditions.
“The availability of a robust protocol to generate and maintain microglia from patients suffering from these conditions allows studying the interaction of neurons and microglia and will facilitate the investigation of these diseases in defined culture conditions.”
Quote in the paperSubstantial claim - Interpretationown data
This highlights a lack of overlap between mesodermal and neuro-ectodermal lineages despite their side-by-side residence in the brain in vivo.
“highlighting the lack of overlap between these mesodermal and neuro-ectodermal lineages, despite their side-by-side residence in the brain, in vivo.”
Quote in the paperNot a substantial claim - Interpretationcitation
The surveying behavior of pMGLs resembles that of microglia in intact mouse brains observed in two-photon imaging studies.
“Their surveying behavior is reminiscent of that observed in vivo in the landmark two-photon imaging studies of the dynamic process motility of microglia in intact mouse brains 38.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [38] Nimmerjahn, A., Kirchhoff, F. & Helmchen, F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308, 1314–1318 (2005). source
Not checked in the free run.
- Premisecitation
Glutamate was left out to avoid its excitotoxic effects in dissociated cultures.
“Glutamate was omitted to avoid the excitotoxicity of this amino-acid in dissociated cultures 47.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [47] Hogins, J., Crawford, D.C., Zorumski, C.F. & Mennerick, S. Excitotoxicity triggered by Neurobasal culture medium. PLoS One 6, e25633 (2011). source
Not checked in the free run.
- Premisecitation
Additional pyruvate and lactic acid were included as energy-providing and neuroprotective substrates alongside standard oxidative substrates.
“We included additional pyruvate48, and lactic acid 49 as energy-providing and neuroprotective substrates in addition to the more canonical oxidative substrates (glucose, galactose and glutamine/Glutamax).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [48] Nakamichi, N. et al. Protection by exogenous pyruvate through a mechanism related to monocarboxylate transporters against cell death induced by hydrogen peroxide in cultured rat cortical neurons. J. Neurochem. 93, 84–93 (2005). source
Not checked in the free run.
- cites [49] Jourdain, P. et al. l-Lactate protects neurons against excitotoxicity: implication of an ATP-mediated signaling cascade. Sci. Rep. 6, 21250 (2016). source
Not checked in the free run.
- May combine two claims. 36
- Classified as probably not a substantial claim. 20
- The quote only partly states this claim. 1
May combine two claims.
Findingown dataMature pMGLs stained positive for markers of murine and human microglia, with TMEM119 and P2RY12 displaying broad membrane and punctate vesicular expression.
“Mature pMGLs stained positive for markers of murine and human microglia 10,11,29,30, with both TMEM119 and P2RY12 displaying a broad membrane and punctate vesicular expression pattern”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [10] Bennett, M.L. et al. New tools for studying microglia in the mouse and human CNS. Proc. Natl. Acad. Sci. USA 113, E1738–E1746 (2016). source
Not checked in the free run.
- cites [11] Hickman, S.E. et al. The microglial sensome revealed by direct RNA sequencing. Nat. Neurosci. 16, 1896–1905 (2013). source
Not checked in the free run.
- cites [29] Butovsky, O. et al. Identification of a unique TGF-β-dependent molecular and functional signature in microglia. Nat. Neurosci. 17, 131–143 (2014). source
Not checked in the free run.
- cites [30] Haynes, S.E. et al. The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat. Neurosci. 9, 1512–1519 (2006). source
Not checked in the free run.
May combine two claims.
Findingown dataImmature pMGLs initially delaminating from YS-EBs are round yet already highly phagocytic, as observed by uptake of fluorescent latex beads and appearance of filopodia and membrane ruffles.
“The immature pMGLs initially delaminating from YS-EBs are round yet already highly phagocytic, as observed by the uptake of fluorescent latex beads and the appearance of filopodia and membrane ruffles”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenNeural progenitors can be expanded by adding FGF2 to the NGD base.
“Neural progenitors can be expanded by addition of FGF2 to the NGD base”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataBoth human fetal microglia and mouse neonatal microglia died when no CSF1R agonist was present.
“Both hFMGs and mNMGs died in the absence of any CSF1R agonist”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe cells can be sorted by FACS and are homogeneously positive for IBA1, CD45 and CD11b.
“These cells can be further sorted by FACS and are homogeneously positive for IBA1, CD45 and CD11b (Fig 2d, e)”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe cells are highly motile and will tax to and encapsulate foreign bodies such as fibers present in the well.
“The cells are highly motile and will readily tax to and encapsulate foreign bodies such as fibers present in the well (Fig. 2f).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataHarvested semi-adherent cells plated on Primaria appear vacuolated, round and motile, and stain positive for PU.1, CD11b and IBA1.
“When harvested and plated separately on Primaria, semi-adherent cells appear vacuolated, round and motile, and stain positive for PU.1, as well as CD11b and IBA1 (AIF1) ((Fig. 2b,c, Supplementary Movie 1).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataClusters of cells delaminated towards the lumen of cysts and directly into the outer medium or onto the plastic culture surface.
“clusters of cells were seen to delaminate towards the lumen of the cysts (Fig. 1e) as well as directly into the outer medium or on the plastic culture surface.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationWhen plated early on poly-D-lysine, neuralized embryoid bodies flattened into rosette-forming neuroepithelium, while cystic embryoid bodies flattened into cell lawns resembling endothelial cells.
“When plated at these early stages on poly-D-lysine, the neuralized EBs flattened into typical rosette-forming neuroepithelium, while the small cystic EBs flattened into cell lawns reminiscent of endothelial cells 18 (Supplementary Fig. 1b).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [18] Palis, J., McGrath, K.E. & Kingsley, P.D. Initiation of hematopoiesis and vasculogenesis in murine yolk sac explants. Blood 86, 156–163 (1995). source
Not checked in the free run.
May combine two claims.
Findingown dataGFP-labeled pMGLs integrated into 3D cultures, tiled the volume, and projected highly branched ramifications.
“GFP-labeled pMGLs, which had adopted rounded to first-order ramified morphologies when cultured on plastic, integrated into the three-dimensional cultures, tiled the volume (Fig. 6c), and projected highly branched ramifications (Fig. 6d).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown datapMGLs migrate to and encapsulate a site of localized injury.
“Furthermore, they respond to localized injury by migrating and encapsulating the damaged area.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown datapMGLs kept in mono-culture express high levels of SELPLG, TXNIP, CST3 and OLFML3, suggesting they adopt a relatively more mature profile than primary fetal cells.
“pMGLs kept in mono-culture express high levels of SELPLG, TXNIP, CST3 and OLFML3, suggesting they adopt a relatively more mature profile than primary fetal cells.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataExposure to undifferentiated neural progenitor conditioned medium maintains the rounded phenotype of immature microglia and promotes their proliferation.
“We observed that exposure to undifferentiated neural progenitor conditioned medium maintains the rounded phenotype of immature microglia and promotes their proliferation.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown datapMGLs form a cluster with both fetal and mature primary microglia, while iPS-derived neural cells cluster with primary neurons and glia, close to fetal astrocytes.
“We find that pMGLs form a cluster with both fetal and mature primary microglia, while iPS-derived neural cells cluster with primary neurons and glia, close to fetal astrocytes (Figure 5b).”
Quote in the paperSubstantial claimMay combine two claims.
Findingnone givenpMGLs bypass a colony-forming monocytic stage, are initially amoeboid and capable of proliferation, extensive migration and phagocytosis.
“In particular, they bypass a colony-forming monocytic stage, are initially amoeboid and capable of proliferation, extensive migration and phagocytosis.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn cultures, SELPLG, CST3 and TXNIP are already expressed at high levels in both FMGs and pMGLs, while OLFML3 and P2RY13 are more than 4-fold higher in pMGLs compared to FMGs.
“In our cultures, we find that SELPLG, CST3 and TXNIP are already expressed at high levels in both FMGs and pMGLs, while OLFML3 and P2RY13 are more than 4-fold higher in pMGLs compared to FMGs.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataAs pMGLs populate the substrate, they isolate from their nearest neighbors, an in vitro behavior that may correspond to the ability of microglia to tile the CNS in vivo.
“As pMGLs populate the substrate, they clearly isolate from their nearest neighbors, an in vitro behavior which may correspond to the ability to tile the CNS by their in vivo counterparts.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationThese genes are expressed at low levels in cultured macrophage cell lines and previously described mouse ES-derived microglia.
“Notably, these genes are expressed at low levels in cultured macrophage cell lines as well as in previously described mouse ES-derived microglia 33.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [33] Beutner, C., Roy, K., Linnartz, B., Napoli, I. & Neumann, H. Generation of microglial cells from mouse embryonic stem cells. Nat. Protoc. 5, 1481–1494 (2010). source
Not checked in the free run.
May combine two claims.
Findingown dataNeural progenitors progressively differentiated into neurons and macro-glia and would be devoid of microglia without exogenous pMGLs.
“The neural progenitors progressively differentiated into neurons and macro-glia (astrocytes, oligodendrocytes), and would be devoid of any microglia without the exogenous addition of pMGLs.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown datapMGLs display high expression of PU.1 and IRF8, but very low levels of MYB.
“We also note that pMGLs display high expression of both PU.1 and IRF8, but very low levels of MYB (Suppl. Fig 3a)”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataThe pluripotent stem cell-derived microglia-like cells faithfully recapitulate the expected ontogeny and characteristics of in vivo microglia and resemble primary fetal human and mouse microglia.
“These in vitro pluripotent stem cell-derived microglia-like cells (termed pMGLs) faithfully recapitulate the expected ontogeny and characteristics of their in vivo counterparts and resemble primary fetal human and mouse microglia.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationPrimary human microglia are poorly characterized, differ greatly from mature mouse microglia, are not easily accessible, and current isolation methods likely alter their defining characteristics.
“primary human microglia remain poorly characterized as they differ greatly from mature mouse microglia, are not easily accessible and current methods employed for isolation likely alter their defining characteristics6.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [6] Smith, A.M., Gibbons, H.M., Lill, C., Faull, R.L. & Dragunow, M. Isolation and culture of adult human microglia within mixed glial cultures for functional experimentation and high-content analysis. Methods Mol. Biol. 1041, 41–51 (2013). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMicroglia leave the yolk sac as erythromyeloid precursors or primitive macrophages before peripheral hematopoiesis begins.
“They emigrate as erythromyeloid precursors or primitive macrophages from the yolk sac, before further hematopoiesis takes place in the periphery.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [4] Ginhoux, F. et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330, 841–845 (2010). source
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationRobust protocols exist for differentiating human ES or iPS cells into neurons, astrocytes and oligodendrocytes.
“Robust protocols have been developed to induce human ES or iPS cells to differentiate into the different neuroectodermal cell types of the CNS including neurons, astrocytes and oligodendrocytes 7,8.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [7] Hu, B.Y., Du, Z.W., Li, X.J., Ayala, M. & Zhang, S.C. Human oligodendrocytes from embryonic stem cells: conserved SHH signaling networks and divergent FGF effects. Development 136, 1443–1452 (2009). source
Not checked in the free run.
- cites [8] Hu, B.Y. & Zhang, S.C. Differentiation of spinal motor neurons from pluripotent human stem cells. Nat. Protoc. 4, 1295–1304 (2009). source
Not checked in the free run.
May combine two claims.
Interpretationown dataThe differentiation protocol is efficient and robust, though the genetic background of the pluripotent donor affects the kinetics and yield of microglia-like cells.
“We conclude that the differentiation protocol is efficient and robust, though the genetic background of the pluripotent donor affects the kinetics and yield of the microglia-like cells.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataMonocultures of pMGLs can serve as a substrate to study functional and morphological changes in microglia derived from isogenic parental cells, or to screen for modulators of inflammation.
“These results indicate that monocultures of pMGLs can be a substrate to study the functional and morphological changes in microglia, derived from isogenic parental cells, or to screen for modulators of inflammation.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningThe modular differentiation system allows microglia to be studied under highly defined conditions as they mature in response to developmental cues and provides a framework for studying long-term interactions in a tissue-like environment.
“This modular differentiation system allows the study of microglia in highly defined conditions, as they mature in response to developmentally relevant cues, and provides a framework to study the long-term interactions of microglia residing in a tissue-like environment.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMouse genetic lineage tracing indicates that microglia colonize the developing neural tube shortly before the blood-brain barrier closes.
“recent genetic lineage tracing in the mouse determined that microglia take up residence in the developing neural tube shortly before closure of the blood-brain barrier 4.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [4] Ginhoux, F. et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330, 841–845 (2010). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThese markers have been extensively used to label or define microglia in various systems.
“These markers have been extensively used to label or define microglia in various systems 24.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [24] Ito, D. et al. Microglia-specific localisation of a novel calcium binding protein, Iba1. Brain Res. Mol. Brain Res. 57, 1–9 (1998). source
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationMyeloid cells can be generated from mouse and human ES cells using protocols that recapitulate classical hematopoiesis followed by monocyte expansion.
“Protocols recapitulating classical hematopoiesis, followed by expansion of monocytes have shown that myeloid cells can be generated from mouse and human ES cells 9.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [9] Grigoriadis, A.E. et al. Directed differentiation of hematopoietic precursors and functional osteoclasts from human ES and iPS cells. Blood 115, 2769–2776 (2010). source
Not checked in the free run.
May combine two claims.
PremisecitationMicroglial identity combines a unique mesodermal ontogeny from primitive myelopoiesis with lifelong residence in an immune-privileged neuro-glial environment.
“microglial identity is a combination of unique mesodermal ontogeny (primitive myelopoiesis) and lifelong residence in an immune-privileged neuro-glial environment.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationPU.1 is necessary for microglial differentiation and maintenance and can induce macrophages from fibroblasts.
“which is necessary for microglial differentiation and maintenance 21,22 and can induce macrophages from fibroblasts 23.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [21] McKercher, S.R. et al. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 15, 5647–5658 (1996). source
Not checked in the free run.
- cites [22] Smith, A.M. et al. The transcription factor PU.1 is critical for viability and function of human brain microglia. Glia 61, 929–942 (2013). source
Not checked in the free run.
- cites [23] Feng, R. et al. PU.1 and C/EBPα/β convert fibroblasts into macrophage-like cells. Proc. Natl. Acad. Sci. USA 105, 6057–6062 (2008). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMicroglia are the resident macrophages of the central nervous system.
“Microglia are the resident macrophages of the central nervous system (CNS) 1.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [1] Tremblay, M.E. et al. The role of microglia in the healthy brain. J. Neurosci. 31, 16064–16069 (2011). source
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationInflammation mediated by microglia can harm the brain.
“Microglia mediated inflammation can have deleterious consequences for the brain and much evidence indicates that microglial activation contributes to neurodegenerative disease such as AD, PD and ALD 40,41.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [40] Aubourg, P. Cerebral adrenoleukodystrophy: a demyelinating disease that leaves the door wide open. Brain 138, 3133–3136 (2015). source
Not checked in the free run.
- cites [41] Ransohoff, R.M. & El Khoury, J. Microglia in health and disease. Cold Spring Harb. Perspect. Biol. 8, a020560 (2015). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIn ALD, phagocytes from autologous bone marrow transplants likely act beneficially by replacing mutant microglia, thereby halting terminal neuro-inflammation and demyelination.
“In ALD, phagocytes derived from autologous bone marrow transplants likely elicit their beneficial effects by replacing mutant microglia, as they stall terminal neuro-inflammation and demyelination 42.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [42] Cartier, N. et al. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 326, 818–823 (2009). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenAll parental cell lines were maintained beyond 50 passages, verified for stable Oct3/4, Nanog, and TRA1-60 expression, and routinely tested for mycoplasma.
“All parental lines were maintained for over 50 passages, verified for stable expression of Oct3/4, Nanog and TRA1-60, and routinely tested for mycoplasma negativity.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataThe sample size was not pre-determined using statistical tests.
“no statistical tests were used to pre-determine sample size.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenAll experiments with human donor cells and animals complied with established IRB protocols at the Whitehead Institute.
“all experiments involving cells from human donors and animals were performed in compliance with established IRB protocols at the Whitehead institute.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown datapMGLs can integrate into organotypic neural cultures and mature into what is currently defined as resting yet dynamically motile microglia.
“These results suggest that pMGLs can integrate into organotypic neural cultures, and mature into what is currently defined as resting yet dynamically motile microglia.”
Quote in the paperSubstantial claim- Rests on an assumption: The 3D organotypic culture and focal laser injury model reproduce relevant in vivo microglial behavior.
May combine two claims.
Interpretationown dataThe difference between NPCs and pMGLs along PC1 may reflect the main myeloid versus neural identity and accounts for about 77% of sample variance.
“The difference between NPCs and pMGLs along PC1 may reflect the main myeloid vs neural identity, accounting for ~77% of sample variance”
Quote in the paperSubstantial claimThe quote only partly states this claim.
Interpretationown dataThe absence of canonical myeloid ontology terms among differentially expressed genes supports the use of pMGLs as a surrogate for human microglia.
“supporting their use as surrogate for human microglia.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
PremisecitationMicroglial activation contributes to neurodegenerative diseases such as AD, PD, and ALD.
“Microglia mediated inflammation can have deleterious consequences for the brain and much evidence indicates that microglial activation contributes to neurodegenerative disease such as AD, PD and ALD 40,41.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [40] Aubourg, P. Cerebral adrenoleukodystrophy: a demyelinating disease that leaves the door wide open. Brain 138, 3133–3136 (2015). source
Not checked in the free run.
- cites [41] Ransohoff, R.M. & El Khoury, J. Microglia in health and disease. Cold Spring Harb. Perspect. Biol. 8, a020560 (2015). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenExperimenters were not blinded to genotype or culture conditions, except in transcriptomic analysis where line genotype was not explicit.
“Experimenters were not blinded to the genotypes or culture conditions, except for transcriptomic where line genotype was not explicit for analysis.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn mouse, several microglia-specific genes are upregulated in brain-resident microglia through early postnatal development.
“In the mouse, several microglia-specific genes appear to be upregulated in brain-resident microglia through early postnatal development 10.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [10] Bennett, M.L. et al. New tools for studying microglia in the mouse and human CNS. Proc. Natl. Acad. Sci. USA 113, E1738–E1746 (2016). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMicroglia carry out key functions in brain development, including circuit refinement, neurogenesis, and neuronal growth.
“It is well established that microglia perform key functions in the development of the brain such as in circuit refinement, neurogenesis, and neuronal growth 39.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [39] Wu, Y., Dissing-Olesen, L., MacVicar, B.A. & Stevens, B. Microglia: dynamic mediators of synapse development and plasticity. Trends Immunol. 36, 605–613 (2015). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationcitationThis is consistent with the current understanding that microglia derive from non-monocytic primitive myeloid precursors, unlike adult bone marrow-derived macrophages but similarly to some other tissue-resident macrophages.
“This is consistent with our current understanding of microglial development, which supports the notion that microglia derive from non-monocytic primitive myeloid cells acting as precursors, unlike adult bone marrow-derived macrophages, but similarly to some other tissue-resident macrophages 37.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [37] Ginhoux, F. & Guilliams, M. Tissue-resident macrophage ontogeny and homeostasis. Immunity 44, 439–449 (2016). source
Not checked in the free run.
May combine two claims.
Interpretationown datapMGLs are highly phagocytic and, based on phenotypic and gene expression profiles, resemble primary fetal and adult human microglia.
“We demonstrated that pMGLs are highly phagocytic and, based on their phenotypic and gene expression profiles, resemble primary fetal and adult human microglia.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningIron salts were omitted and iron-loaded transferrin used instead to prevent dangerous redox cycling via Fenton chemistry.
“Iron salts were excluded, instead using iron-loaded transferrin in Neurobasal, in order to avoid dangerous redox cycling through Fenton chemistry.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenBiotin and lipid-loaded albumin were added to support de novo synthesis of lipid bilayers such as axons and myelin sheaths.
“Biotin and lipid-loaded albumin (Albumax) were added to support de novo synthesis lipid bilayers (e.g. axons, myelin sheaths).”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIonic concentrations were set to match human cerebrospinal fluid osmolality, providing extracellular sodium levels required for proper electrophysiological function.
“Ionic concentrations were chosen to match human cerebrospinal fluid osmolality 45, thus providing extracellular sodium concentrations necessary for proper electrophysiological function.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [45] Harrington, M.G. et al. Cerebrospinal fluid sodium rhythms. Cerebrospinal Fluid Res. 7, 3 (2010). source
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe NGD medium component concentrations were adjusted to match human cerebrospinal fluid, supplying metabolic substrates needed by individual cell types grown without others.
“We adjusted the component concentrations to match those of human cerebrospinal fluid, providing metabolic substrates necessary for individual cell types growing in the absence of others.”
Quote in the paperSubstantial claim
The paper relies on this without support.
Neuroglial derivatives from neural progenitors are poorly adherent on Primaria and are therefore selected against by this substrate.
“In contrast, neuroglial derivatives from neural progenitors are poorly adherent, and thus selected against on this substrate (not shown).”
The paper relies on this without support.
Human fetal microglia maintained in the same culture conditions retain characteristics of bona fide primary microglia and are a valid reference for comparison.
“Isolated human fetal microglia and pMGLs were grown in the same maintenance medium for a week (MGM).”
The paper relies on this without support.
The 3D organotypic culture and focal laser injury model reproduce relevant in vivo microglial behavior.
“We took advantage of our 3D culture system to model such localized damage and observe microglial behavior in real-time.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Protocols have been developed to produce human iPSC-derived microglial-like cells (iMG).
“Recently, protocols for induce human iPSC-derived microglial-like cells (iMG) have been developed [67-71].”
From Transcriptional and Epigenetic Regulation of Microglia in Health and Disease (2019) · cites this paper as [67]
iMG can integrate into organotypic 3D culture.
“iMG can integrate into organotypic 3D culture [67].”
From Transcriptional and Epigenetic Regulation of Microglia in Health and Disease (2019) · cites this paper as [67]
When co-cultured with iPSC-derived neurons, iMG are more motile and secrete fewer cytokines than in monoculture.
“When co-cultured with iPSC-derived neurons, iMG display a more motile phenotype and dampened secretion of cytokines compared to monoculture [67, 68].”
From Transcriptional and Epigenetic Regulation of Microglia in Health and Disease (2019) · cites this paper as [67]
iMG have a transcriptomic phenotype closer to human microglia in vitro than ex vivo microglia.
“iMG exhibited a transcriptomic phenotype more similar to human microglia in vitro than ex vivo microglia. (Table 4) [22, 67, 68].”
From Transcriptional and Epigenetic Regulation of Microglia in Health and Disease (2019) · cites this paper as [67]
The Muffat et al. approach uses hematopoietic cells derived from embryoid bodies as microglial precursors.
“their approach uses hematopoietic cells derived from embryoid bodies (EB) as microglia precursors”
From iPSC-derived human microglia-like cells to study neurological diseases (2017) · cites this paper as Muffat et al., 2016
Several iPSC models have been obtained from skin fibroblasts of cALD and AMN patients.
“Several iPSC models have successfully been obtained from skin fibroblasts of cALD and AMN patients [ 143 , 144 , 145 , 146 , 147 ]”
From Peroxisomal ABC Transporters: An Update (2021) · cites this paper as [146]
Differentiated microglia from iPSC show the main phenotype of primary fetal and adult human microglia including phagocytic and inflammatory capacity.
“differentiated microglia show the main phenotype of primary fetal and adult human microglia including phagocytic and inflammatory capacity [ 146 ]”
From Peroxisomal ABC Transporters: An Update (2021) · cites this paper as [146]
Cites
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827 · see citing works
Zhang, Y., Chen, K., Sloan, S. A., Bennett, M. L., Scholze, A. R., O'Keeffe, S., Phatnani, H. P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1860-14.2014 · Cited by 5,508 · see citing works
Protective and pathogenic functions of macrophage subsets
Murray, P. J., & Wynn, T. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3073 · Cited by 5,269 · see citing works
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., Mehler, M. F., Conway, S. J., Ng, L. G., Stanley, E. R., et al. (2010) · Science · doi:10.1126/science.1194637 · Cited by 5,175 · see citing works
Identification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,579 · see citing works
Self-citationA Lineage of Myeloid Cells Independent of Myb and Hematopoietic Stem Cells
Schulz, C., Perdiguero, E. G., Chorro, L., Szabo-Rogers, H., Cagnard, N., Kierdorf, K., Prinz, M., Wu, B., Jacobsen, S. E. W., Pollard, J. W., et al. (2012) · Science · doi:10.1126/science.1219179 · Cited by 2,578 · see citing works
Tissue-Resident Macrophage Ontogeny and Homeostasis
Ginhoux, F., & Guilliams, M. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.024 · Cited by 1,884 · see citing works
New tools for studying microglia in the mouse and human CNS
Bennett, M. L., Bennett, F. C., Liddelow, S. A., Ajami, B., Zamanian, J. L., Fernhoff, N. B., Mulinyawe, S. B., Bohlen, C. J., Adil, A., Tucker, A., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525528113 · Cited by 1,804 · see citing works
The P2Y12 receptor regulates microglial activation by extracellular nucleotides
Haynes, S. E., Hollopeter, G., Yang, G., Kurpius, D., Dailey, M. E., Gan, W.-B., & Julius, D. (2006) · Nature Neuroscience · doi:10.1038/nn1805 · Cited by 1,542 · see citing works
The microglial sensome revealed by direct RNA sequencing
Hickman, S. E., Kingery, N. D., Ohsumi, T. K., Borowsky, M. L., Wang, L.-C., Means, T. K., & El Khoury, J. (2013) · Nature Neuroscience · doi:10.1038/nn.3554 · Cited by 1,511 · see citing works
Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy
Cartier, N., Hacein-Bey-Abina, S., Bartholomae, C. C., Veres, G., Schmidt, M., Kutschera, I., Vidaud, M., Abel, U., Dal-Cortivo, L., Caccavelli, L., et al. (2009) · Science · doi:10.1126/science.1171242 · Cited by 1,508 · see citing works
Self-citationMicroglia-specific localisation of a novel calcium binding protein, Iba1
Ito, D., Imai, Y., Ohsawa, K., Nakajima, K., Fukuuchi, Y., & Kohsaka, S. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00040-0 · Cited by 1,476 · see citing works
Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways
Kierdorf, K., Erny, D., Goldmann, T., Sander, V., Schulz, C., Perdiguero, E. G., Wieghofer, P., Heinrich, A., Riemke, P., Hölscher, C., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3318 · Cited by 1,468 · see citing works
Hoeffel, G., Chen, J., Lavin, Y., Low, D., Almeida, F. F., See, P., Beaudin, A. E., Lum, J., Low, I., Forsberg, E. C., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.03.011 · Cited by 1,135 · see citing works
Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities
McKercher, S. R., Torbett, B. E., Anderson, K. L., Henkel, G. W., Vestal, D. J., Baribault, H., Klemsz, M., Feeney, A. J., Wu, G. E., Paige, C. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00949.x · Cited by 1,130 · see citing works
Wang, Y., Szretter, K. J., Vermi, W., Gilfillan, S., Rossini, C., Cella, M., Barrow, A. D., Diamond, M. S., & Colonna, M. (2012) · Nature Immunology · doi:10.1038/ni.2360 · Cited by 1,011 · see citing works
The Role of Microglia in the Healthy Brain: Figure 1.
Tremblay, M.-È., Stevens, B., Sierra, A., Wake, H., Bessis, A., & Nimmerjahn, A. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4158-11.2011 · Cited by 992 · see citing works
Depression as a Microglial Disease
Yirmiya, R., Rimmerman, N., & Reshef, R. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.08.001 · Cited by 944 · see citing works
Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain
Alliot, F., Godin, I., & Pessac, B. (1999) · Developmental Brain Research · doi:10.1016/s0165-3806(99)00113-3 · Cited by 884 · see citing works
Soldner, F., Laganière, J., Cheng, A. W., Hockemeyer, D., Gao, Q., Alagappan, R., Khurana, V., Golbe, L. I., Myers, R. H., Lindquist, S., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.019 · Cited by 728 · see citing works
Self-citationMicroglia: Dynamic Mediators of Synapse Development and Plasticity
Wu, Y., Dissing-Olesen, L., MacVicar, B. A., & Stevens, B. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.08.008 · Cited by 661 · see citing works
Wild-type microglia arrest pathology in a mouse model of Rett syndrome
Derecki, N. C., Cronk, J. C., Lu, Z., Xu, E., Abbott, S. B. G., Guyenet, P. G., & Kipnis, J. (2012) · Nature · doi:10.1038/nature10907 · Cited by 607 · see citing works
New insights on the role of microglia in synaptic pruning in health and disease
Hong, S., Dissing-Olesen, L., & Stevens, B. (2016) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2015.12.004 · Cited by 557 · see citing works
Sturgeon, C. M., Ditadi, A., Awong, G., Kennedy, M., & Keller, G. (2014) · Nature Biotechnology · doi:10.1038/nbt.2915 · Cited by 467 · see citing works
Origin of microglia: current concepts and past controversies
Ginhoux, F., & Prinz, M. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a020537 · Cited by 446 · see citing works
Neuronal medium that supports basic synaptic functions and activity of human neurons in vitro
Bardy, C., van den Hurk, M., Eames, T., Marchand, C., Hernandez, R. V., Kellogg, M., Gorris, M., Galet, B., Palomares, V., Brown, J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1504393112 · Cited by 428 · see citing works
Lengner, C. J., Gimelbrant, A. A., Erwin, J. A., Cheng, A. W., Guenther, M. G., Welstead, G. G., Alagappan, R. K., Frampton, G. M., Xu, P. A., Muffat, J., et al. (2010) · Cell · doi:10.1016/j.cell.2010.04.010 · Cited by 398 · see citing works
Self-citationWei, S., Nandi, S., Chitu, V., Yeung, Y.-G., Yu, W., Huang, M., Williams, L. T., Lin, H., & Stanley, E. R. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.1209822 · Cited by 370 · see citing works
Ontogeny of Tissue-Resident Macrophages
Hoeffel, G., & Ginhoux, F. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00486 · Cited by 364 · see citing works
PU.1 and C/EBPα/β convert fibroblasts into macrophage-like cells
Feng, R., Desbordes, S. C., Xie, H., Tillo, E. S., Pixley, F., Stanley, E. R., & Graf, T. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711961105 · Cited by 348 · see citing works
Li, Y., Wang, H., Muffat, J., Cheng, A. W., Orlando, D. A., Lovén, J., Kwok, S., Feldman, D., Bateup, H. S., Gao, Q., et al. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.09.001 · Cited by 305 · see citing works
Self-citationNS21: Re-defined and modified supplement B27 for neuronal cultures
Chen, Y., Stevens, B., Chang, J., Milbrandt, J., Barres, B. A., & Hell, J. W. (2008) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2008.03.013 · Cited by 304 · see citing works
Microglia in Health and Disease
Ransohoff, R. M., & Khoury, J. E. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a020560 · Cited by 303 · see citing works
Self-citationDifferentiation of spinal motor neurons from pluripotent human stem cells
Hu, B.-Y., & Zhang, S.-C. (2009) · Nature Protocols · doi:10.1038/nprot.2009.127 · Cited by 298 · see citing works
Initiation of hematopoiesis and vasculogenesis in murine yolk sac explants
Palis, J., McGrath, K., & Kingsley, P. (1995) · Blood · doi:10.1182/blood.v86.1.156.bloodjournal861156 · Cited by 198 · see citing works
Hu, B.-Y., Du, Z.-W., Li, X.-J., Ayala, M., & Zhang, S.-C. (2009) · Development · doi:10.1242/dev.029447 · Cited by 169 · see citing works
Zhou, J., Su, P., Li, D., Tsang, S., Duan, E., & Wang, F. (2010) · Stem Cells · doi:10.1002/stem.504 · Cited by 168 · see citing works
Grigoriadis, A. E., Kennedy, M., Bozec, A., Brunton, F., Stenbeck, G., Park, I.-H., Wagner, E. F., & Keller, G. M. (2010) · Blood · doi:10.1182/blood-2009-07-234690 · Cited by 151 · see citing works
The transcription factor PU.1 is critical for viability and function of human brain microglia
Smith, A. M., Gibbons, H. M., Oldfield, R. L., Bergin, P. M., Mee, E. W., Faull, R. L. M., & Dragunow, M. (2013) · Glia · doi:10.1002/glia.22486 · Cited by 142 · see citing works
L-Lactate protects neurons against excitotoxicity: implication of an ATP-mediated signaling cascade
Jourdain, P., Allaman, I., Rothenfusser, K., Fiumelli, H., Marquet, P., & Magistretti, P. J. (2016) · Scientific Reports · doi:10.1038/srep21250 · Cited by 116 · see citing works
The role of microglia in brain maintenance: implications for Rett syndrome
Derecki, N. C., Cronk, J. C., & Kipnis, J. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.10.002 · Cited by 99 · see citing works
Generation of microglial cells from mouse embryonic stem cells
Beutner, C., Roy, K., Linnartz, B., Napoli, I., & Neumann, H. (2010) · Nature Protocols · doi:10.1038/nprot.2010.90 · Cited by 85 · see citing works
Microglia can be induced by IFN-γ or IL-4 to express neural or dendritic-like markers
Butovsky, O., Bukshpan, S., Kunis, G., Jung, S., & Schwartz, M. (2007) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2007.04.009 · Cited by 76 · see citing works
Cerebrospinal fluid sodium rhythms
Harrington, M. G., Salomon, R. M., Pogoda, J. M., Oborina, E., Okey, N., Johnson, B., Schmidt, D., Fonteh, A. N., & Dalleska, N. F. (2010) · Cerebrospinal Fluid Research · doi:10.1186/1743-8454-7-3 · Cited by 56 · see citing works
Vitry, S., Bertrand, J. Y., Cumano, A., & Dubois-Dalcq, M. E. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-33-10724.2003 · Cited by 52 · see citing works
Nakamichi, N., Kambe, Y., Oikawa, H., Ogura, M., Takano, K., Tamaki, K., Inoue, M., Hinoi, E., & Yoneda, Y. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.02999.x · Cited by 52 · see citing works
Excitotoxicity Triggered by Neurobasal Culture Medium
Hogins, J., Crawford, D. C., Zorumski, C. F., & Mennerick, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025633 · Cited by 41 · see citing works
Innate immune responses in the brain of sphingolipid lysosomal storage diseases
Vitner, E. B., Futerman, A. H., & Platt, N. (2015) · Biological Chemistry · doi:10.1515/hsz-2014-0301 · Cited by 29 · see citing works
Smith, A. M., Gibbons, H. M., Lill, C., Faull, R. L. M., & Dragunow, M. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-520-0_6 · Cited by 18 · see citing works
Cerebral adrenoleukodystrophy: a demyelinating disease that leaves the door wide open: Figure 1
Aubourg, P. (2015) · Brain · doi:10.1093/brain/awv271 · Cited by 15 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Microglia emerge as central players in brain disease
Salter, M. W., & Stevens, B. (2017) · Nature Medicine · doi:10.1038/nm.4397 · Cited by 1,767 · see citing works
Microglia in neurodegeneration
Hickman, S., Izzy, S., Sen, P., Morsett, L., & El Khoury, J. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0242-x · Cited by 1,710 · see citing works
Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets
Gao, C., Jiang, J., Tan, Y., & Chen, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01588-0 · Cited by 1,616 · see citing works
Microglia Biology: One Century of Evolving Concepts
Prinz, M., Jung, S., & Priller, J. (2019) · Cell · doi:10.1016/j.cell.2019.08.053 · Cited by 1,525 · see citing works
Microglia in physiology and disease
Wolf, S. A., Boddeke, H. W. G. M., & Kettenmann, H. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034406 · Cited by 1,426 · see citing works
An environment-dependent transcriptional network specifies human microglia identity
Gosselin, D., Skola, D., Coufal, N. G., Holtman, I. R., Schlachetzki, J. C. M., Sajti, E., Jaeger, B. N., O’Connor, C., Fitzpatrick, C., Pasillas, M. P., et al. (2017) · Science · doi:10.1126/science.aal3222 · Cited by 1,252 · see citing works
Self-citationLin, Y.-T., Seo, J., Gao, F., Feldman, H. M., Wen, H.-L., Penney, J., Cam, H. P., Gjoneska, E., Raja, W. K., Cheng, J., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.05.008 · Cited by 1,125 · see citing works
Self-citationMicroglial signatures and their role in health and disease
Butovsky, O., & Weiner, H. L. (2018) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0057-5 · Cited by 1,046 · see citing works
iPSC-derived human microglia-like cells to study neurological diseases
Abud, E. M., Ramirez, R. N., Martinez, E. S., Healy, L. M., Nguyen, C. H. H., Newman, S. A., Yeromin, A. V., Scarfone, V. M., Marsh, S. E., Fimbres, C., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.03.042 · Cited by 1,154 · see citing works
Transcriptomic analysis of purified human cortical microglia reveals age-associated changes
Galatro, T. F., Holtman, I. R., Lerario, A. M., Vainchtein, I. D., Brouwer, N., Sola, P. R., Veras, M. M., Pereira, T. F., Leite, R. E. P., Möller, T., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4597 · Cited by 766 · see citing works
TREM2 regulates microglial cholesterol metabolism upon chronic phagocytic challenge
Nugent, A. A., Lin, K., van Lengerich, B., Lianoglou, S., Przybyla, L., Davis, S. S., Llapashtica, C., Wang, J., Kim, D. J., Xia, D., et al. (2020) · Neuron · doi:10.1016/j.neuron.2019.12.007 · Cited by 745 · see citing works
Microglia and Central Nervous System–Associated Macrophages—From Origin to Disease Modulation
Prinz, M., Masuda, T., Wheeler, M. A., & Quintana, F. J. (2021) · Annual Review of Immunology · doi:10.1146/annurev-immunol-093019-110159 · Cited by 584 · see citing works
Haenseler, W., Sansom, S. N., Buchrieser, J., Newey, S. E., Moore, C. S., Nicholls, F. J., Chintawar, S., Schnell, C., Antel, J. P., Allen, N. D., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.05.017 · Cited by 593 · see citing works
A transcriptomic atlas of aged human microglia
Olah, M., Patrick, E., Villani, A.-C., Xu, J., White, C. C., Ryan, K. J., Piehowski, P., Kapasi, A., Nejad, P., Cimpean, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-02926-5 · Cited by 482 · see citing works
APOE4/4 is linked to damaging lipid droplets in Alzheimer’s disease microglia
Haney, M. S., Pálovics, R., Munson, C. N., Long, C., Johansson, P. K., Yip, O., Dong, W., Rawat, E., West, E., Schlachetzki, J. C. M., et al. (2024) · Nature · doi:10.1038/s41586-024-07185-7 · Cited by 536 · see citing works
“Differentiation into microglia was performed as previously described 17–19 .”
Modeling Alzheimer’s disease with iPSC-derived brain cells
Penney, J., Ralvenius, W. T., & Tsai, L.-H. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0468-3 · Cited by 471 · see citing works
Self-citationMcQuade, A., Coburn, M., Tu, C. H., Hasselmann, J., Davtyan, H., & Blurton-Jones, M. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0297-x · Cited by 449 · see citing works
An Efficient Platform for Astrocyte Differentiation from Human Induced Pluripotent Stem Cells
TCW, J., Wang, M., Pimenova, A. A., Bowles, K. R., Hartley, B. J., Lacin, E., Machlovi, S. I., Abdelaal, R., Karch, C. M., Phatnani, H., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.06.018 · Cited by 435 · see citing works
Macrophages at CNS interfaces: Ontogeny and function in health and disease
Kierdorf, K., Masuda, T., Jordão, M. J. C., & Prinz, M. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0201-x · Cited by 416 · see citing works
Differentiation of human and murine induced pluripotent stem cells to microglia-like cells
Pandya, H., Shen, M. J., Ichikawa, D. M., Sedlock, A. B., Choi, Y., Johnson, K. R., Kim, G., Brown, M. A., Elkahloun, A. G., Maric, D., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4534 · Cited by 405 · see citing works
Development of prefrontal cortex
Kolk, S. M., & Rakic, P. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-021-01137-9 · Cited by 378 · see citing works
“Microglia cells, on the other hand, are of mesodermal origin and migrate throughout the brain [55].”
BackgroundDirected differentiation of human pluripotent stem cells to microglia
Douvaras, P., Sun, B., Wang, M., Kruglikov, I., Lallos, G., Zimmer, M., Terrenoire, C., Zhang, B., Gandy, S., Schadt, E., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.04.023 · Cited by 381 · see citing works
The pro-remyelination properties of microglia in the central nervous system
Lloyd, A. F., & Miron, V. E. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0184-2 · Cited by 381 · see citing works
Microglia: Agents of the CNS Pro-Inflammatory Response
Rodríguez-Gómez, J. A., Kavanagh, E., Engskog-Vlachos, P., Engskog, M. K. R., Herrera, A. J., Espinosa-Oliva, A. M., Joseph, B., Hajji, N., Venero, J. L., & Burguillos, M. A. (2020) · Cells · doi:10.3390/cells9071717 · Cited by 365 · see citing works
Th17 lymphocytes induce neuronal cell death in a human iPSC-based model of Parkinson's disease
Sommer, A., Marxreiter, F., Krach, F., Fadler, T., Grosch, J., Maroni, M., Graef, D., Eberhardt, E., Riemenschneider, M. J., Yeo, G. W., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.06.015 · Cited by 332 · see citing works
McCauley, H. A., & Wells, J. M. (2017) · Development · doi:10.1242/dev.140731 · Cited by 322 · see citing works
The promises and challenges of human brain organoids as models of neuropsychiatric disease
Quadrato, G., Brown, J., & Arlotta, P. (2016) · Nature Medicine · doi:10.1038/nm.4214 · Cited by 304 · see citing works
A Map of Transcriptional Heterogeneity and Regulatory Variation in Human Microglia
Young, A. M. H., Kumasaka, N., Calvert, F., Hammond, T. R., Knights, A., Panousis, N., Park, J. S., Schwartzentruber, J., Liu, J., Kundu, K., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00875-2 · Cited by 213 · see citing works
Andreone, B. J., Przybyla, L., Llapashtica, C., Rana, A., Davis, S. S., van Lengerich, B., Lin, K., Shi, J., Mei, Y., Astarita, G., et al. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0650-6 · Cited by 233 · see citing works
Functional Studies of Missense TREM2 Mutations in Human Stem Cell-Derived Microglia
Brownjohn, P. W., Smith, J., Solanki, R., Lohmann, E., Houlden, H., Hardy, J., Dietmann, S., & Livesey, F. J. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.03.003 · Cited by 193 · see citing works
Trapecar, M., Wogram, E., Svoboda, D., Communal, C., Omer, A., Lungjangwa, T., Sphabmixay, P., Velazquez, J., Schneider, K., Wright, C. W., et al. (2021) · Science Advances · doi:10.1126/sciadv.abd1707 · Cited by 176 · see citing works
Self-citationXiang, X., Piers, T. M., Wefers, B., Zhu, K., Mallach, A., Brunner, B., Kleinberger, G., Song, W., Colonna, M., Herms, J., et al. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0280-6 · Cited by 170 · see citing works
Microglia and Astrocyte Function and Communication: What Do We Know in Humans?
Garland, E. F., Hartnell, I. J., & Boche, D. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.824888 · Cited by 165 · see citing works
Garcia-Reitboeck, P., Phillips, A., Piers, T. M., Villegas-Llerena, C., Butler, M., Mallach, A., Rodrigues, C., Arber, C. E., Heslegrave, A., Zetterberg, H., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.07.094 · Cited by 162 · see citing works
An updated assessment of microglia depletion: current concepts and future directions
Han, J., Harris, R. A., & Zhang, X.-M. (2017) · Molecular Brain · doi:10.1186/s13041-017-0307-x · Cited by 141 · see citing works
Human iPSC‐derived microglia: A growing toolset to study the brain's innate immune cells
Hasselmann, J., & Blurton‐Jones, M. (2020) · Glia · doi:10.1002/glia.23781 · Cited by 145 · see citing works
Stem cell models of Alzheimer’s disease: progress and challenges
Arber, C., Lovejoy, C., & Wray, S. (2017) · Alzheimer's Research & Therapy · doi:10.1186/s13195-017-0268-4 · Cited by 143 · see citing works
Transcriptional and Epigenetic Regulation of Microglia in Health and Disease
Yeh, H., & Ikezu, T. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.11.004 · Cited by 135 · see citing works
Piers, T. M., Cosker, K., Mallach, A., Johnson, G. T., Guerreiro, R., Hardy, J., & Pocock, J. M. (2020) · The FASEB Journal · doi:10.1096/fj.201902447r · Cited by 135 · see citing works
Antignano, I., Liu, Y., Offermann, N., & Capasso, M. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04775-y · Cited by 117 · see citing works
Guo, J. L., Braun, D., Fitzgerald, G. A., Hsieh, Y.-T., Rougé, L., Litvinchuk, A., Steffek, M., Propson, N. E., Heffner, C. M., Discenza, C., et al. (2025) · Cell · doi:10.1016/j.cell.2024.10.027 · Cited by 91 · see citing works
Li, L., Chao, J., & Shi, Y. (2018) · Cell and Tissue Research · doi:10.1007/s00441-017-2713-x · Cited by 89 · see citing works
Peroxisomal ABC Transporters: An Update
Tawbeh, A., Gondcaille, C., Trompier, D., & Savary, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116093 · Cited by 68 · see citing works
Human iPSC-derived glia models for the study of neuroinflammation
Stöberl, N., Maguire, E., Salis, E., Shaw, B., & Hall-Roberts, H. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02919-2 · Cited by 71 · see citing works
Genome Editing in iPSC-Based Neural Systems: From Disease Models to Future Therapeutic Strategies
McTague, A., Rossignoli, G., Ferrini, A., Barral, S., & Kurian, M. A. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.630600 · Cited by 67 · see citing works
Cell Fate Reprogramming in the Era of Cancer Immunotherapy
Zimmermannova, O., Caiado, I., Ferreira, A. G., & Pereira, C.-F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.714822 · Cited by 56 · see citing works
Garcia, G., Pinto, S., Ferreira, S., Lopes, D., Serrador, M. J., Fernandes, A., Vaz, A. R., Mendonça, A. D., Edenhofer, F., Malm, T., et al. (2022) · Cells · doi:10.3390/cells11213377 · Cited by 55 · see citing works
“Since the recent development of differentiation protocols to obtain microglia (or microglia-like cells) from iPSCs, several studies have emerged that used them to examine the effects of AD-linked mutations or to identify new risk factors [21,26,103,104].”
BackgroundIsolation and Phenotyping of Adult Mouse Microglial Cells
Grabert, K., & McColl, B. W. (2018) · Methods in Molecular Biology · doi:10.1007/978-1-4939-7837-3_7 · Cited by 48 · see citing works
Microcephaly Modeling of Kinetochore Mutation Reveals a Brain-Specific Phenotype
Omer Javed, A., Li, Y., Muffat, J., Su, K.-C., Cohen, M. A., Lungjangwa, T., Aubourg, P., Cheeseman, I. M., & Jaenisch, R. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.09.032 · Cited by 46 · see citing works
Self-citationRedefining Microglial Identity in Health and Disease at Single-Cell Resolution
Provenzano, F., Pérez, M. J., & Deleidi, M. (2021) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.09.001 · Cited by 45 · see citing works
Human iPSC application in Alzheimer’s disease and tau-related neurodegenerative diseases
TCW, J. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.01.043 · Cited by 39 · see citing works
Novel human iPSC models of neuroinflammation in neurodegenerative disease and regenerative medicine
Summers, R. A., Fagiani, F., Rowitch, D. H., Absinta, M., & Reich, D. S. (2024) · Trends in Immunology · doi:10.1016/j.it.2024.08.004 · Cited by 39 · see citing works
Bartalska, K., Hübschmann, V., Korkut-Demirbaş, M., Cubero, R. J. A., Venturino, A., Rössler, K., Czech, T., & Siegert, S. (2022) · iScience · doi:10.1016/j.isci.2022.104580 · Cited by 22 · see citing works
Cerebral adrenoleukodystrophy: a demyelinating disease that leaves the door wide open: Figure 1
Aubourg, P. (2015) · Brain · doi:10.1093/brain/awv271 · Cited by 15 · see citing works
Self-citation
- Authors
- Muffat, J., Li, Y., Yuan, B., Mitalipova, M., Omer, A., Corcoran, S., Bakiasi, G., Tsai, L.-H., Aubourg, P., Ransohoff, R. M., & Jaenisch, R.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Université Paris-Sud (FR)
- Bryn Mawr College (US)
- Massachusetts Institute of Technology (US)
- Biogen (United States) (US)
- Corresponding author
- Jaenisch, Rudolf
- ORCID
- Venue
- Nature Medicine
- Published
- 2016-09-26
- Volume
- 22
- Issue
- 11
- Pages
- 1358-1367
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- PMC
- PMC5101156
- OpenAlex
- W2525538087
- Semantic Scholar
- 7b38bfb134631f7ab7fe2f4f2b3bf5fb0475b9a5
- Cited by
- 651
- References
- 50
- Citations by year
- 2026: 45 · 2025: 58 · 2024: 70 · 2023: 48 · 2022: 76 · 2021: 86 · 2020: 74 · 2019: 59 · 2018: 80 · 2017: 44 · 2016: 8 · 2015: 1
- FWCI
- 33.10
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- PMC
- Funders
- Howard Hughes Medical Institute
- Simons Foundation (SFARI 204106)
- International Rett Syndrome Foundation
- Amgen
- Biogen
- National Alliance for Research on Schizophrenia and Depression
- Simons Foundation Autism Research Initiative
- Emerald Foundation
- Association Européenne contre les Leucodystrophies
- National Institutes of Health (2r01ca084198-10, 1rf1ag048029-01, 1rf1ag042978-01, HD 045022)
- Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology
- Bhabha Atomic Research Centre
- National Institute on Aging (RF1-AG048029, RF1-AG042978)
- National Institute of Mental Health (R01MH104610)
- National Cancer Institute (R01-CA084198, R37CA084198)
- National Institute of Neurological Disorders and Stroke (R01NS088538)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD045022, R37HD045022)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- microglia-like cells, human pluripotent stem cells, embryonic stem cells, induced pluripotent stem cells, microglia differentiation, serum-free culture, Rett syndrome, neurodegenerative diseases
- MeSH terms
- Human Embryonic Stem Cells, Cell Differentiation, Humans, Organ Culture Techniques, Rett Syndrome, Microglia, Induced Pluripotent Stem Cells, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review